Mass spectrometric determination of apolipoprotein molecular stoichiometry in reconstituted high density lipoprotein particles

Journal of Lipid Research

Volumn 50, Issue 6, 2009, Pages 1229-1236

  Massey, John B ^a   Pownall, Henry J ^a   Macha, Stephen ^b   Morris, Jamie ^c   Tubb, Matthew R ^c   Silva, R A Gangani D ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein A I; Cholesterol; Matrix assisted laser desorption ionization mass spectrometry; Phospholipids

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; HIGH DENSITY LIPOPROTEIN; RECONSTITUTED HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; STOICHIOMETRY;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS; APOLIPOPROTEINS A; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEIN ELECTROPHORESIS; CROSS-LINKING REAGENTS; DIMYRISTOYLPHOSPHATIDYLCHOLINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIPOPROTEINS, HDL; LIPOSOMES; PHOSPHATIDYLCHOLINES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 67650535225     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D800044-JLR200     Document Type: Article

References (32)

1. Rader, D. J. 2006. Molecular regulation of HDL metabolism and function: implications for novel therapies. J. Clin. Invest. 116: 3090-3100.
2. Barter, P. J., and K. A. Rye. 2006. The rationale for using apoA-I as a clinical marker of cardiovascular risk. J. Intern. Med. 259: 447-454.
3. Barter, P., J. Kastelein, A. Nunn, and R. Hobbs. 2003. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis. 168: 195-211.
4. Joy, T., and R. A. Hegele. 2008. Is raising HDL a futile strategy for atheroprotection? Nat. Rev. Drug Discov. 7: 143-155.
5. Jonas, A. 2002. Lipoprotein Structure. In Biochemistry of Lipids, Lipoproteins and Membranes. D. E. Vance and J. E. Vance, editors. Elsevier Science, Amsterdam. 483-504.
6. Kontush, A., and M. J. Chapman. 2006. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58: 342-374.
7. Movva, R., and D. J. Rader. 2008. Laboratory assessment of HDL heterogeneity and function. Clin. Chem. 54: 788-800.
8. Silva, R. A., R. Huang, J. Morris, J. Fang, E. O. Gracheva, G. Ren, A. Kontush, W. G. Jerome, K. A. Rye, and W. S. Davidson. 2008. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc. Natl. Acad. Sci. USA. 105: 12176-12181.
9. Silva, R. A., L. A. Schneeweis, S. C. Krishnan, X. Zhang, P. H. Axelsen, and W. S. Davidson. 2007. The structure of apolipoprotein A-II in discoidal high density lipoproteins. J. Biol. Chem. 282: 9713-9721.
10. Martin, D. D., M. S. Budamagunta, R. O. Ryan, J. C. Voss, and M. N. Oda. 2006. Apolipoprotein A-I assumes a "looped belt" conformation on reconstituted high density lipoprotein. J. Biol. Chem. 281: 20418-20426.
11. Denis, M., B. Haidar, M. Marcil, M. Bouvier, L. Krimbou, and J. Genest, Jr. 2004. Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding Cassette Transporter A1 (ABCA1). J. Biol. Chem. 279: 7384-7394.
12. Duong, P. T., H. L. Collins, M. Nickel, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2006. Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I. J. Lipid Res. 47: 832-843.
13. Liu, L., A. E. Bortnick, M. Nickel, P. Dhanasekaran, P. V. Subbaiah, S. Lund-Katz, G. H. Rothblat, and M. C. Phillips. 2003. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J. Biol. Chem. 278: 42976-42984.
14. Cavigiolio, G., B. Shao, E. G. Geier, G. Ren, J. W. Heinecke, and M. N. Oda. 2008. The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses. Biochemistry. 47: 4770-4779.
15. Toledo, J. D., M. A. Tricerri, B. Corsico, and H. A. Garda. 2000. Cholesterol flux between lipid vesicles and apolipoprotein AI discs of variable size and composition. Arch. Biochem. Biophys. 380: 63-70.
16. Wu, Z., M. A. Wagner, L. Zheng, J. S. Parks, J. M. Shy III, J. D. Smith, V. Gogonea, and S. L. Hazen. 2007. The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction. Nat. Struct. Mol. Biol. 14: 861-868.
17. Frank, P. G., and Y. L. Marcel. 2000. Apolipoprotein A-I: structure-function relationships. J. Lipid Res. 41: 853-872.
18. Swaney, J. B., and K. O'Brien. 1978. Cross-linking studies of the self-association properties of apo- A-I and apo-A-II from human high density lipoprotein. J. Biol. Chem. 253: 7069-7077.
19. Bhat, S., M. G. Sorci-Thomas, E. T. Alexander, M. P. Samuel, and M. J. Thomas. 2005. Intermolecular contact between globular N-terminal fold and C-terminal domain of ApoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry. J. Biol. Chem. 280: 33015-33025.
20. Massey, J. B., and H. J. Pownall. 2008. Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I. Biochim. Biophys. Acta. 1781: 245-253.
21. Lund-Katz, S., and M. C. Phillips. 1986. Packing of cholesterol molecules in human low-density lipoprotein. Biochemistry. 25: 1562-1568.
22. Tubb, M. R., R. A. G. D. Silva, K. J. Pearson, P. Tso, M. Liu, and W. S. Davidson. 2007. Modulation of apolipoprotein A-IV lipid binding by an interaction between the N and C termini. J. Biol. Chem. 282: 28385-28394.
23. Pearson, K., M. R.Tubb, M. Tanaka, X. Q. Zhang, P. Tso, R. B. Weinberg, and W. S. Davidson. 2005. Specific sequences in the N and C termini of apolipoprotein A-IV modulate its conformation and lipid association. J. Biol. Chem. 280: 38576-38582.
24. Maiorano, J. N., R. J. Jandacek, E. M. Horace, and W. S. Davidson. 2004. Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size. Biochemistry. 43: 11717-11726.
25. Weinberg, R. B., and M. K. Jordan. 1990. Effects of phospholipid on the structure of human apolipoprotein A-IV. J. Biol. Chem. 265: 8081-8086.
26. Davidson, W. S., and G. M. Hilliard. 2003. The spatial organization of apolipoprotein A-I on the edge of discoidal high density lipoprotein particles: a mass spectrometry study. J. Biol. Chem. 278: 27199-27207.
27. Silva, R. A., G. M. Hilliard, L. Li, J. P. Segrest, and W. S. Davidson. 2005. A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins. Biochemistry. 44: 8600-8607.
28. Asztalos, B. F., E. J. Schaefer, K. V. Horvath, S. Yamashita, M. Miller, G. Franceschini, and L. Calabresi. 2007. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J. Lipid Res. 48: 592-599.
29. Silva, R. A., G. M. Hilliard, J. Fang, S. Macha, and W. S. Davidson. 2005. A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. Biochemistry. 44: 2759-2769.
30. Bhat, S., M. G. Sorci-Thomas, R. Tuladhar, M. P. Samuel, and M. J. Thomas. 2007. Conformational adaptation of apolipoprotein A-I to discretely sized phospholipid complexes. Biochemistry. 46: 7811-7821.
31. Tubb, M. R., R. A. Silva, J. Fang, P. Tso, and W. S. Davidson. 2008. A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry. J. Biol. Chem. 283: 17314-17323.
32. Jonas, A., A. Steinmetz, and L. Churgay. 1993. The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles. J. Biol. Chem. 268: 1596-1602.